ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 162 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2018. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,085,000 | +13.0% | 46,985 | -0.2% | 0.01% | +16.7% |
| Q2 2018 | $1,845,000 | -28.2% | 47,061 | +32.5% | 0.01% | +100.0% |
| Q1 2018 | $2,568,000 | -1.3% | 35,514 | -10.2% | 0.01% | 0.0% |
| Q4 2017 | $2,603,000 | -5.7% | 39,528 | -28.3% | 0.01% | 0.0% |
| Q3 2017 | $2,761,000 | +15.4% | 55,095 | +6.6% | 0.01% | 0.0% |
| Q2 2017 | $2,392,000 | +1096.0% | 51,667 | +508.1% | 0.01% | +500.0% |
| Q3 2015 | $200,000 | -93.8% | 8,496 | -78.5% | 0.00% | -87.5% |
| Q2 2015 | $3,229,000 | – | 39,489 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $22,344,000 | 10.09% |
| Altium Capital Management LP | 2,515,785 | $12,579,000 | 3.47% |
| Deep Track Capital, LP | 5,641,668 | $28,208,000 | 1.99% |
| Paradigm Biocapital Advisors LP | 839,257 | $4,196,000 | 1.20% |
| SABBY MANAGEMENT, LLC | 940,400 | $4,702,000 | 0.68% |
| Monaco Asset Management SAM | 500,000 | $2,500,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,000,000 | $25,000,000 | 0.52% |
| CVI Holdings, LLC | 1,460,595 | $7,303,000 | 0.48% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $13,566,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,000,000 | $4,960,000 | 0.33% |